Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL17817765 | 1.00 | MAPT (0.36) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| Fluoride SCHEMBL28157025 | 0.98 | MAPT (0.34) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL8924 | 0.98 | MAPT (0.37) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL3662203 | 0.98 | MAPT (0.37) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL29804885 | 0.98 | MAPT (0.37) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL16341187 | 0.98 | MAPT (0.37) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL7679307 | 0.95 | MAPT (0.36) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL7679297 | 0.95 | MAPT (0.36) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL3201327 | 0.95 | MAPT (0.36) | MAPTGAAKDM4EMEN1ALDH1A1 | |
| SCHEMBL21822066 | 0.95 | MAPT (0.36) | MAPTGAAKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542391-B2 | Hardener component for multi-component epoxy resin material, and multi-component epoxy resin material | HILTI AKTIENGESELLSCHAFT (LI) | 2023-01-03 | — | — | US | claimed |
| CN-111247190-B | Hardener component for a multi-component epoxy resin material and multi-component epoxy resin material | 喜利得股份公司 | 2022-11-04 | — | — | CN | claimed |
| EP-3853280-A1 | CURING COMPOSITION FOR EPOXY RESIN COMPOSITION, EPOXY RESIN COMPOSITION, AND MULTI-COMPONENT EPOXY RESIN SYSTEM | Hilti Aktiengesellschaft (LI) | 2021-07-28 | — | — | EP | claimed |
| CN-109456674-B | Water-based epoxy resin coating and application thereof in automobile corrosion prevention | 湖北大学 | 2021-01-26 | — | — | CN | claimed |
| US-20200362161-A1 | Hardener component for multi-component epoxy resin material, and multi-component epoxy resin material | HILTI AKTIENGESELLSCHAFT (LI) | 2020-11-19 | — | — | US | claimed |
| EP-3724252-A1 | HARDENER COMPONENT FOR MULTI-COMPONENT EPOXY RESIN MATERIAL, AND MULTI-COMPONENT EPOXY RESIN MATERIAL | Hilti Aktiengesellschaft (LI) | 2020-10-21 | — | — | EP | claimed |
| CN-111247190-A | Hardener component for a multicomponent epoxy resin material and multicomponent epoxy resin material | 喜利得股份公司 | 2020-06-05 | — | — | CN | claimed |
| WO-2020058016-A1 | CURING COMPOSITION FOR EPOXY RESIN COMPOSITION, EPOXY RESIN COMPOSITION, AND MULTI-COMPONENT EPOXY RESIN SYSTEM | HILTI AKTIENGESELLSCHAFT (LI) | 2020-03-26 | — | — | WO | claimed |
| CN-106750285-B | A kind of fluorine-containing nitrogen benzoxazine polymer-type fire retardant and preparation method thereof | 厦门大学 | 2019-07-30 | — | — | CN | claimed |
| CN-109456674-A | A kind of aqueous epoxide resin paint and its application in automobile anti-corrosion | 湖北大学 | 2019-03-12 | — | — | CN | claimed |
| CN-106750285-A | A kind of fluorine-containing nitrogen benzoxazine polymer-type fire retardant and preparation method thereof | 厦门大学 | 2017-05-31 | — | — | CN | claimed |
| CN-103224735-B | Benzoxazine-modified epoxy glass printing ink and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2014-11-12 | — | — | CN | claimed |
| CN-103224735-A | Benzoxazine-modified epoxy glass printing ink and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2013-07-31 | — | — | CN | claimed |
| EP-4584333-A1 | TWO COMPONENT COMPOSITION BASED ON A BLEND OF EPOXIDE COMPOUNDS | Henkel AG & Co. KGaA (DE) | 2025-07-16 | — | — | EP | disclosed |
| US-20250207003-A1 | TWO COMPONENT COMPOSITION BASED ON A BLEND OF EPOXIDE COMPOUNDS | HENKEL AG & CO KGAA (DE) | 2025-06-26 | — | — | US | disclosed |
| US-20250177412-A1 | SMALL-MOLECULE INHIBITORS TARGETING THE BOB1/OCT1 INTERFACE | NANTES UNIVERSITE (FR) | 2025-06-05 | — | — | US | disclosed |
| US-4557979-A | ELECTROPHORESIS OF A NEUTRALIZED BLEND OF A POLY-1,3-BENZOXAZINE AND REACTIVE POLYAMINE; PROTECTIVE COATINGS | MONSANTO COMPANY (US) | 1985-12-10 | — | — | US | disclosed |
| EP-0149989-A2 | Aqueous dispersions of polyamines and poly (dihydrobenzoxazines) | Monsanto Company (US) | 1985-07-31 | — | — | EP | disclosed |
| EP-0147382-A2 | Process for deposition of resin dispersions on metal substrates | Monsanto Company (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4507428-A | CATIONIC RESINS FOR PRIMERS AND PROTECTIVE COATINGS | MONSANTO COMPANY (US) | 1985-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177412-A1 | SMALL-MOLECULE INHIBITORS TARGETING THE BOB1/OCT1 INTERFACE | POU2F1, POU5F1, LEF1 | MAPT 2095/4885GAA 1254/4885KDM4E 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.